FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.0  |  FHIR Version n/a  User: [n/a]

900000000000508004: Great Britain English language reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001112010 Great Britain English language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001113017 GB English en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001114011 Great Britain English language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

1233160 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
GB English Is a English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept) true Inferred relationship Some
Members acceptabilityId
5-HT3 receptor antagonist Preferred (foundation metadata concept)
5-HT3 receptor antagonist-containing product Preferred (foundation metadata concept)
5-HT3-receptor antagonist adverse reaction Preferred (foundation metadata concept)
5-HT3-receptor antagonist allergy Acceptable (foundation metadata concept)
5-HT3-receptor antagonist overdose Preferred (foundation metadata concept)
5-HT3-receptor antagonist overdose of undetermined intent Preferred (foundation metadata concept)
5-HT3-receptor antagonist poisoning Preferred (foundation metadata concept)
5-HT3-receptor antagonist poisoning of undetermined intent Preferred (foundation metadata concept)
5-He Acceptable (foundation metadata concept)
5-Hydroxy-indoleacetic acid Preferred (foundation metadata concept)
5-Hydroxy-indoleacetic acid (substance) Preferred (foundation metadata concept)
5-Hydroxyhexanoate measurement Preferred (foundation metadata concept)
5-Hydroxyhexanoate measurement (procedure) Preferred (foundation metadata concept)
5-Hydroxyindoleacetic acid Preferred (foundation metadata concept)
5-Hydroxyindoleacetic acid (substance) Preferred (foundation metadata concept)
5-Hydroxyindoleacetic acid measurement Preferred (foundation metadata concept)
5-Hydroxyindoleacetic acid measurement (procedure) Preferred (foundation metadata concept)
5-Hydroxyindoleacetic acid measurement, quantitative, urine Preferred (foundation metadata concept)
5-Hydroxyindoleacetic acid measurement, quantitative, urine (procedure) Preferred (foundation metadata concept)
5-Hydroxyindoleacetic acid/creatinine ratio measurement Preferred (foundation metadata concept)
5-Hydroxyindoleacetic acid/creatinine ratio measurement (procedure) Preferred (foundation metadata concept)
5-Hydroxytryptamine measurement Acceptable (foundation metadata concept)
5-Hydroxytryptamine release Acceptable (foundation metadata concept)
5-Hydroxytryptamine release measurement Preferred (foundation metadata concept)
5-Hydroxytryptamine release measurement (procedure) Preferred (foundation metadata concept)
5-Hydroxytryptamine uptake Acceptable (foundation metadata concept)
5-Hydroxytryptamine uptake measurement Preferred (foundation metadata concept)
5-Hydroxytryptamine uptake measurement (procedure) Preferred (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist adverse reaction Acceptable (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist adverse reaction (disorder) Preferred (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist overdose Acceptable (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist overdose (disorder) Preferred (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist overdose of undetermined intent Acceptable (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist overdose of undetermined intent (disorder) Preferred (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist poisoning Acceptable (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist poisoning (disorder) Preferred (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist poisoning of undetermined intent Acceptable (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist poisoning of undetermined intent (disorder) Preferred (foundation metadata concept)
5-Hydroxytryptophan measurement Preferred (foundation metadata concept)
5-Hydroxytryptophan measurement (procedure) Preferred (foundation metadata concept)
5-O-(4-coumaroyl)-D-quinate 3'-monooxygenase Preferred (foundation metadata concept)
5-O-(4-coumaroyl)-D-quinate 3'-monooxygenase (substance) Preferred (foundation metadata concept)
5-O-(4-coumaroyl)-D-quinate/shikimate 3'-hydroxylase Acceptable (foundation metadata concept)
5-OH indole acetic acid (& level (& urine)) Preferred (foundation metadata concept)
5-OH indole acetic acid (& level (& urine)) Preferred (foundation metadata concept)
5-OH indole acetic acid (& level (& urine)) (procedure) Preferred (foundation metadata concept)
5-OH indole acetic acid (& level (& urine)) (procedure) Preferred (foundation metadata concept)
5-Oxoprolinase deficiency Preferred (foundation metadata concept)
5-Oxoprolinase deficiency (disorder) Preferred (foundation metadata concept)
5-Oxoproline Preferred (foundation metadata concept)
5-Oxoproline (substance) Preferred (foundation metadata concept)
5-Oxoproline + pipecolate Preferred (foundation metadata concept)
5-Oxoproline + pipecolate (substance) Preferred (foundation metadata concept)
5-Oxoproline measurement Preferred (foundation metadata concept)
5-Oxoproline measurement (procedure) Preferred (foundation metadata concept)
5-Oxoprolinuria Acceptable (foundation metadata concept)
5-WAY LEPTOSPIROSIS VACCINE Preferred (foundation metadata concept)
5-WAY LEPTOSPIROSIS VACCINE (product) Preferred (foundation metadata concept)
5-alpha reductase deficiency Acceptable (foundation metadata concept)
5-alpha reductase inhibitor Preferred (foundation metadata concept)
5-alpha reductase inhibitor Preferred (foundation metadata concept)
5-alpha reductase inhibitor (disposition) Preferred (foundation metadata concept)
5-alpha reductase inhibitor-containing product Preferred (foundation metadata concept)
5-alpha tetrahydro-11-dehydrocorticosterone Preferred (foundation metadata concept)
5-alpha tetrahydro-11-dehydrocorticosterone (substance) Preferred (foundation metadata concept)
5-alpha-Tetrahydrocortisol measurement Preferred (foundation metadata concept)
5-alpha-Tetrahydrocortisol measurement (procedure) Preferred (foundation metadata concept)
5-alpha-dihydrotestosterone Acceptable (foundation metadata concept)
5-alpha-tetrahydrocortisol Preferred (foundation metadata concept)
5-alpha-tetrahydrocortisol (substance) Preferred (foundation metadata concept)
5-amino-4-imidazole carboxamide ribosiduria Preferred (foundation metadata concept)
5-amino-4-imidazole carboxamide ribosiduria (disorder) Preferred (foundation metadata concept)
5-amino-6-(5-phosphoribosylamino) uracil reductase Preferred (foundation metadata concept)
5-amino-6-(5-phosphoribosylamino) uracil reductase (substance) Preferred (foundation metadata concept)
5-aminolevulinate Preferred (foundation metadata concept)
5-aminolevulinate (substance) Preferred (foundation metadata concept)
5-aminolevulinate dehydratase Acceptable (foundation metadata concept)
5-aminolevulinate synthase Preferred (foundation metadata concept)
5-aminolevulinate synthase (substance) Preferred (foundation metadata concept)
5-aminolevulinic acid Preferred (foundation metadata concept)
5-aminolevulinic acid (substance) Preferred (foundation metadata concept)
5-aminolevulinic acid hydrochloride Acceptable (foundation metadata concept)
5-aminolevulinic acid only product Preferred (foundation metadata concept)
5-aminolevulinic acid only product in cutaneous dose form Preferred (foundation metadata concept)
5-aminolevulinic acid-containing product Preferred (foundation metadata concept)
5-aminolevulinic acid-containing product in cutaneous dose form Preferred (foundation metadata concept)
5-aminopentanamidase Preferred (foundation metadata concept)
5-aminopentanamidase (substance) Preferred (foundation metadata concept)
5-aminosalicylic acid Acceptable (foundation metadata concept)
5-aminosalicylic acid Preferred (foundation metadata concept)
5-aminosalicylic acid (substance) Preferred (foundation metadata concept)
5-aminosalicylic acid adverse reaction Acceptable (foundation metadata concept)
5-aminosalicylic acid adverse reaction (disorder) Preferred (foundation metadata concept)
5-aminosalicylic acid allergy Acceptable (foundation metadata concept)
5-aminosalicylic acid allergy Acceptable (foundation metadata concept)
5-aminosalicylic acid overdose Preferred (foundation metadata concept)
5-aminosalicylic acid overdose (disorder) Preferred (foundation metadata concept)
5-aminosalicylic acid overdose of undetermined intent Preferred (foundation metadata concept)
5-aminosalicylic acid overdose of undetermined intent (disorder) Preferred (foundation metadata concept)
5-aminosalicylic acid poisoning Preferred (foundation metadata concept)
5-aminosalicylic acid poisoning (disorder) Preferred (foundation metadata concept)

Start Previous Page 117 of 12332 Next End

Reference Sets

Reference set descriptor

Back to Start